LINEZOLID GXP linezolid 600 mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

linezolid, Quantity: 600 mg

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

Designació comuna internacional (DCI):

Linezolid

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: povidone; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; sodium dihydrogen citrate; titanium dioxide; hypromellose; PEG-40 stearate

Vía de administración:

Oral

Unidades en paquete:

30, 10

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Resumen del producto:

Visual Identification: Off-white, oblong, biconvex, film-coated tablet.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2016-01-28